These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

112 related items for PubMed ID: 9424015

  • 21. Antinociceptive effects of monoamine reuptake inhibitors administered alone or in combination with mu opioid agonists in rhesus monkeys.
    Gatch MB, Negus SS, Mello NK.
    Psychopharmacology (Berl); 1998 Jan; 135(1):99-106. PubMed ID: 9489939
    [Abstract] [Full Text] [Related]

  • 22. Paradoxical relationship between RAVE (relative activity versus endocytosis) values of several opioid receptor agonists and their liability to cause dependence.
    Wang YH, Sun JF, Tao YM, Xu XJ, Chi ZQ, Liu JG.
    Acta Pharmacol Sin; 2010 Apr; 31(4):393-8. PubMed ID: 20228826
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Opioid agonist and antagonist treatment differentially regulates immunoreactive mu-opioid receptors and dynamin-2 in vivo.
    Yoburn BC, Purohit V, Patel K, Zhang Q.
    Eur J Pharmacol; 2004 Sep 13; 498(1-3):87-96. PubMed ID: 15363980
    [Abstract] [Full Text] [Related]

  • 29. Prohormone convertase 2 (PC2) null mice have increased mu opioid receptor levels accompanied by altered morphine-induced antinociception, tolerance and dependence.
    Lutfy K, Parikh D, Lee DL, Liu Y, Ferrini MG, Hamid A, Friedman TC.
    Neuroscience; 2016 Aug 04; 329():318-25. PubMed ID: 27208618
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Synthesis and biological evaluation of 14-alkoxymorphinans. 20. 14-phenylpropoxymetopon: an extremely powerful analgesic.
    Schütz J, Spetea M, Koch M, Aceto MD, Harris LS, Coop A, Schmidhammer H.
    J Med Chem; 2003 Sep 11; 46(19):4182-7. PubMed ID: 12954070
    [Abstract] [Full Text] [Related]

  • 34. A potent mu-opioid receptor agonist, dihydroetorphine, fails to produce the conditioned place preference in mice.
    Tokuyama S, Nakamura F, Nakao K, Takahashi M, Kaneto H.
    Jpn J Pharmacol; 1996 Aug 11; 71(4):357-60. PubMed ID: 8886936
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Opioid interactions in rhesus monkeys: effects of delta + mu and delta + kappa agonists on schedule-controlled responding and thermal nociception.
    Stevenson GW, Folk JE, Linsenmayer DC, Rice KC, Negus SS.
    J Pharmacol Exp Ther; 2003 Dec 11; 307(3):1054-64. PubMed ID: 14557380
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.